...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.
【24h】

Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.

机译:成人每日口服阿奇霉素预防泰国西部间日疟原虫的随机,对照,双盲试验。

获取原文
获取原文并翻译 | 示例
           

摘要

We assessed the prophylactic efficacy of azithromycin (250 mg/day) against malaria in 276 adults in western Thailand in a randomized, double-blind, placebo-controlled trial. After antimalarial suppressive treatment, volunteers were randomized in a 2:1 ratio to either the azithromycin or placebo, respectively. Study medication was given for an average of 74 days. The azithromycin group (n = 179) had five endpoint parasitemias (1 Plasmodium vivax and 4 P. falciparum), and the placebo group (n = 97) had 28 endpoint parasitemias (21 P. vivax, 5 P. falciparum, and 2 mixed infections). Adverse events and compliance and withdrawal rates were similar in both groups. The protective efficacy (PE) of azithromycin was 98% for P. vivax (95% confidence interval [CI] = 88-100%). There were too few cases to reliably estimate the efficacy of azithromycin for P. falciparum (PE =71%, 95% C =-14-94%). We conclude that daily azithromycin was safe, well-tolerated, and had a high efficacy for the prevention of P. vivax malaria.
机译:在一项随机,双盲,安慰剂对照试验中,我们在泰国西部的276名成年人中评估了阿奇霉素(250毫克/天)对疟疾的预防效果。经过抗疟疾抑制治疗后,将志愿者分别以2:1的比例随机分配给阿奇霉素或安慰剂。研究药物平均给予74天。阿奇霉素组(n = 179)有5个端点寄生虫病(1个间日疟原虫和4个恶性疟原虫),而安慰剂组(n = 97)有28个端点寄生虫病(21个间日疟原虫,5个恶性疟原虫和2个混合性寄生虫病)感染)。两组的不良事件,依从性和戒断率相似。阿奇霉素对间日疟原虫的保护效力为98%(95%置信区间[CI] = 88-100%)。很少有病例能够可靠地估计阿奇霉素对恶性疟原虫的疗效(PE = 71%,95%C = -14-94%)。我们得出的结论是,每日阿奇霉素安全,耐受性好,对预防间日疟原虫疟疾具有很高的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号